MENU

en menu

Articles

  • KSBNS 2024

Article Tools

View Full Text Abstract
Article as PDF Print this Article
Pubmed PMC
PubReader Export to Citation
Email Alerts Open Access

Share this article on :

Stats or Metrics

Related articles in EN

Article

Original Article

Exp Neurobiol 2018; 27(6): 472-488

Published online December 28, 2018

https://doi.org/10.5607/en.2018.27.6.472

© The Korean Society for Brain and Neural Sciences

Developmental Exposure to Di-(2-ethylhexyl) Phthalate Induces Cerebellar Granule Cell Apoptosis via the PI3K/AKT Signaling Pathway

Yuanyuan Fu†, Jing Dong†, Jianan Wang, Mingdan You, Lingling Wei, Hui Fu, Yuan Wang, and Jie Chen*

Department of Occupational and Environmental Health, School of Public Health, China Medical University, Shenyang 110122, China.

Correspondence to: *To whom correspondence should be addressed.
TEL: 86-24-31939406, FAX: 86-24-31939406
e-mail: jchen@cmu.edu.cn
†These authors are contributed equally to this work.

Received: September 25, 2018; Revised: December 11, 2018; Accepted: December 12, 2018

Abstract

Di-(2-ethylhexyl) phthalate (DEHP) is an ubiquitous environmental contaminant because of its extensive use in plastics and its persistence. As an environmental endocrine disruptor, it is suspected to interfere with neurodevelopment in people. However, evidence of the effects of maternal DEHP exposure on cerebellar development in offspring is scarce. The objective of this study was to investigate maternal exposure to DEHP and its effect on apoptosis of cerebellar granule cells (CGCs) and related mechanisms. Pregnant Wistar rats were administrated DEHP (0, 30, 300 and 750 mg/kg/d) by gavage from gestational day (GD) 0 to postnatal day (PN) 21. Primary CGCs were also exposed to mono-(2-ethylhexyl) phthalate (MEHP), the main metabolite of DEHP, for 24 h with concentrations of 0, 25, 100 and 250 µM. The CGCs of male offspring from 300 and 750 mg/kg/d DEHP exposure groups showed significantly increased apoptosis. In addition, the PI3K/AKT signaling pathway was inhibited in the male offspring of the 300 and 750 mg/kg/d DEHP exposure groups. However, effects on female pups were not obvious. Apoptosis was also elevated and the PI3K/AKT signaling pathway was inhibited after primary CGCs were exposed to MEHP. Furthermore, apoptosis was reduced after treatment with the PI3K/AKT signaling pathway activator, insulin-like growth factor (IGF) 1, and increased after treatment with LY294002, an inhibitor of the PI3K/AKT signaling pathway. These results suggested that maternal DEHP exposure induced apoptosis in the CGCs of male pups via the PI3K/AKT signaling pathway, and the apoptosis could be rescued by IGF1 and aggravated by LY294002.

Graphical Abstract


Keywords: DEHP, Cerebellar granule cell, Apoptosis, PI3K/AKT signaling pathway

INTRODUCTION

Di (2-ethylhexyl) phthalate (DEHP) is a kind of endocrine disrupting compound that is often added to polyvinyl chloride materials to increase plasticity [1]. It is widely used in food packaging materials, building decoration materials, children's toys and medical equipment, as well as other products [2,3,4]. DEHP and plastic substrates combine with non-covalent bonds. Therefore, DEHP constantly escapes from plastic products to pollute the atmosphere, soil and water, and ultimately have adverse impacts on human health [5,6]. Humans are exposed to DEHP through various ways predominantly through food intake, but also by drinking water, skin absorption and intravenous injection [7,8]. After DEHP enters the body, it can rapidly metabolize to mono-(2-ethylhexyl) phthalate (MEHP), its primary metabolite, in the gastrointestinal tract and other tissues [9,10]. MEHP is believed to be the main way in DEHP exerts toxic effects since it is 10 times more toxic than its parent compound [11].

It has been thought that women, especially pregnant women, are more susceptible to DEHP than men in the same living environment [12]. Moreover, it was deemed that DEHP and MEHP could pass through the placental barrier and the imperfect fetal cerebral blood barrier to affect fetal development [13,14,15]. Studies have shown that maternal exposure to DEHP exerted deleterious effects on fetal immune, cardiovascular and endocrine system development [16,17,18,19]. Lately, there has been increasing concern regarding maternal DEHP exposure on fetal neural development. However, most of these studies have focused on epidemiological investigations.

In neural development, the normal function of cerebellum plays an important role [20,21]. It is widely considered that altered cerebellar structure and function are associated with emotional, cognitive and social behavior abnormalities [22,23]. Proliferation, differentiation and apoptosis are pivotal steps during early postnatal cerebellar development, and disturbances in any of these may lead to changes in cerebellar function and structure [24,25,26]. It is generally believed that the process of apoptosis is strictly regulated by the organism to maintain the stability of various tissues and organs [27]. However, excessive cell proliferation and apoptosis can ensue when the regulation of apoptosis is unbalanced, which leads to the occurrence of related diseases such as Alzheimer's disease, brain injury and several chronic neurodegenerative disease [28,29,30,31]. Accumulating evidence suggests that the PI3K/AKT signaling pathway is closely related to neuronal apoptosis [32,33]. The PI3K/AKT signaling pathway exists in all mammalian cells and is regulated by a series of extracellular signals such as growth factors and cytokines [34]. It regulates cell survival by phosphorylating a series of downstream targets such as Bcl-2 family members and the caspase family of proteins. Bcl-2 is an important downstream effector of the PI3K/AKT signaling pathway, which is negatively related to regulation of apoptosis [35,36]. When PI3K-dependent AKT is activated, Bcl-2 depolymerizes with phosphorylated Bad and free Bcl-2 can play an anti-apoptotic role. Bax also belongs to the Bcl2 family and acts as a pro-apoptotic factor [37,38]. As an activator of the PI3K/AKT signaling pathway, insulin like growth factor-1 (IGF1) can reduce apoptosis induced by the inhibition of the PI3K/AKT signaling pathway [39], while a chemical inhibitor, LY294002, can inhibit the PI3K/AKT signaling pathway.

Although numerous studies on DEHP neurotoxicity have been conducted [15,40,41,42,43,44,45,46], relatively little research has been done on its effect on the cerebellum, notably, toxicities and related mechanisms are still unclear. Therefore, the aim of the present study was to investigate the effects of DEHP on apoptosis in cerebellar granule cells (CGCs) and the underlying mechanisms involved.

MATERIALS AND METHODS

Animals

Female Wistar rats (230~250 g) were obtained from the Center for Experimental Animals at China Medical University (Shenyang, China) with a National Animal Use License number of SCXKLN2013-0007. All experiments and surgical procedures were approved by the Animal Use and Care Committee at China Medical University, which complies with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. All efforts were made to minimize the number of animals used and their suffering. Rats were housed at a temperature of 24±1℃ with 12 h light/12 h dark cycles. DEHP-free food and water were provided ad libitum.

DEHP administration

Female Wistar rats were randomly assigned to four groups (n=10 per group): the control (only corn oil was administered) and three DEHP treatment groups. Female rats were fed for 1 week and then mated with normal male rats (♀/♂=2:1). The day of the vaginal plug was taken as gestational day (GD) 0. Then pregnant rats were administered, via oral gavage, 0, 30 mg/kg/d, 300 mg/kg/d and 750 mg/kg/d of DEHP (Sigma-Aldrich, St Louis, MO, USA) in 0.1 ml corn oil (Sigma-Aldrich)/20 g body weight from GD 0 to postnatal day (PN) 21. This dose range was selected with reference to the effects on neurodevelopment measured in previous studies [41,47].

Primary CGC isolation and treatment

Primary cultures of CGCs were prepared from 7-day-old Wistar rats and cultured as previously described using a modified method [48,49]. In brief, the cerebellum was dissected and kept in Hank's Buffered Salt Solution after the meninges were carefully removed. Then the cerebella were sliced and tissue was dissociated by 0.125% trypsin solution (Invitrogen, Carlsbad, CA, USA) for 15 min at 37℃, and triturated in the presence of DNase I (Genview Scientific, Tallahassee, Florida, USA) and a few drops of fetal bovine serum (Cellmax, Beijing, China). Dissociated cells were collected by centrifugation and resuspended in basal Dulbecco's Modified Eagle Medium supplemented with 10% fetal bovine serum and penicillin-streptomycin (Invitrogen). The cell suspension was plated on poly-l-lysine-coated petri dishes and cultured in a CO2 incubator. The medium was changed to neuronal culture medium consisting of neurobasal A (Thermo Fisher, Waltham, MA, USA), B27 (Thermo Fisher), glutamine (Sigma-Aldrich) and penicillinstreptomycin after 18 h of culture. Meanwhile, cytarabine (Med-ChemExpress, Monmouth Junction, NJ, USA) was added to inhibit the growth of non-neuronal cells. The culture medium was changed every two days.

After 7 days of cell culture, the culture medium was switched to that containing the indicated concentration of MEHP (AccuStandard, New Haven, CT, USA) MEHP was dissolved in dimethyl sulfoxide (DMSO) because of its poor water-solubility to a final concentration of 0.05%, which has no effect on cell development. The medium from the control group contained the same content of DMSO. IGF1 (R&D Systems, Minneapolis, MN, USA) and LY294002 (MedChemExpress) were added for the indicated periods.

Cell viability assay

The cell viability assay was performed with a Cell Counting Kit-8 (CCK-8; MedChemExpress) according to the manufacturer's instructions. Briefly, cells were seeded in 96-well plates and treated with different concentrations of MEHP, CCK-8 solutions were then added and incubated for 4 h. Absorption at 450 nm was subsequently measured on a Varioskan Flash (Thermo Fisher). Each experiment was repeated three times. Results were expressed as a percentage of the control that was set as 1.

Terminal deoxynucleotidyl transferase-mediated dUTP nick-and labeling (TUNEL) assay

Terminal deoxynucleotidyl transferase-mediated dUTP nick-and labeling (TUNEL) assay was performed on cerebellum paraffin-embedded tissue sections and primary CGCs using an in situ cell death detection kit (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's instructions. Briefly, cell smears were washed using phosphate buffered saline (PBS) and fixed with 4% paraformaldehyde solution for 25 min. Cells were then washed with PBS again and permeabilized using 0.2% Triton X-100 (Sigma-Aldrich). Tissue sections were heated at 60℃ for 2 h, followed by washing in xylene and rehydration through a graded series of ethanols and double-distilled water. Sections were then incubated with 20 µg/ml proteinase K working solution (Beyotime, Shanghai, China) for 30 min at 37℃. Finally, cell smears and paraffin sections were labeled by TUNEL reaction mixture, and incubated at 37℃ in a humidified dark chamber for 1 h. Images were obtained using a fluorescence microscope (Olympus, Tokyo, Japan) under the same conditions of light illumination and at a magnification of ×200 (objective ×20 and ocular ×10). TUNEL-positive cells were counted in a blinded manner only if structures were identified clearly. Three different fields were selected from inner granule layer regions per section, respectively, and three sections per animal were evaluated to obtain a mean value. Six male and six female rats per group were used to obtain an overall mean value for subsequent statistical analysis.

Immunofluorescence

Primary CGCs were fixed and permeabilized as previously described, and then blocked with goat serum (ZhongShan Biotechnology, Beijing, China) for 30 min at room temperature. Cells were then incubated with mouse monoclonal anti-β-IIItubulin (1:400; Abcam, Cambridge, MA, USA) and rabbit anti-cleaved caspase 3 (1:100, Cell Signaling Technology, Danvers, MA, USA) overnight at 4℃. Next day, after washing in PBS three times, a secondary antibody conjugated to the fluorescent markers TRITC or FITC (1:100, Zhong Shan Biotechnology) was added for 2 h. Images were obtained by fluorescence microscopy (Olympus, Japan) at a magnification of 200× (objective 20× and ocular 10×).

Western blotting

Proteins of pups' cerebella at PN 7, and PN 14 from each group were prepared as previously described. Cells were lysed using a total protein extraction kit (Invent Biotechnologies, Plymouth, MN, USA) for animal tissue and cultured cells according to the manufacturer's instructions. The concentration of protein in tissue lysates was estimated by a Pierce BCA protein assay kit (Thermo Fisher) and diluted to 3 µg/µl. Samples were then separated on 10% SDS-acrylamide gels. Proteins were separated by applying a constant voltage of 100 V for 1.5 h and then transferred onto polyvinylidene difluoride membranes at a constant voltage of 100 V for 60 min. After blocking nonspecific sites with Tris-buffered saline (TBS) containing 0.1% Tween 20 and 5% defatted dried milk, membranes were washed and incubated with rabbit anti-p-AKT (1:1000; Cell Signaling Technology), rabbit anti-AKT (1:1000; Cell Signaling Technology), rabbit anti-PI3K (1:1000; Cell Signaling Technology), rabbit anti-Bax (1:1000; Cell Signaling Technology), rabbit anti-cleaved caspase 3 (1:1000; Cell Signaling Technology), mouse- anti-Bcl2 (0.2 µg/ml; R&D Systems), rabbit anti-caspase-3 (1:1000; Cell Signaling Technology) and rabbit anti-β-actin (1:1000; Cell Signaling Technology) overnight at 4℃. Membranes were then incubated with goat anti-rabbit or mouse anti-goat horseradish peroxidase-conjugated secondary antibody (1:2500; ZhongShan Biotechnology). Finally, blots were visualized using the Bioanalytical Imaging System (Azure Biosystems, Dublin, CA, USA). The relative density of each blot was quantified via Image-Pro Plus 6.0 software (Media Cybernetics, Rockville, MD, USA).

Statistics

All analyses were carried out by SPSS software, version 21.0 (SPSS Inc., Chicago, IL, USA), and all experiments were performed at least in triplicate. Data on the net optical density of bands was presented as the means±standard deviations (SD), and a one-way analysis of variance followed by the Bonferroni test was used to compare the treated groups with the control group. Several independent sample nonparametric tests were used to compare the different groups, and the Kruskal-Wallis test was used to compare treated and control groups. A p value of <0.05 was considered statistically significant.

RESULTS

Effects of maternal DEHP exposure on cerebellar granule cell apoptosis in pups

The TUNEL assay is a widely used for evaluating the apoptosis of cells [50], and caspase-3 is a key executor of apoptosis [51]. To determine whether DEHP exposure played a role in apoptosis, TUNEL assay was performed on cerebellum sections at PN 7 and PN 14. TUNEL positive cells in male pups from the 300 and 750 mg/kg/d exposure groups were significantly increased when compared with those of the control group at PN 7 (Fig. 1C. Male: p<0.05) and PN 14 (Fig. 1D. Male: p<0.05). However, for female offspring, significant changes were not observed at PN 7 and PN 14 (Fig. 1C, Female; Fig. 1D, Female). Consistent with these results, the expression of cleaved caspase-3 in male pups' of the 300 mg/kg/d and 750 mg/kg/d exposure groups was significantly also increased when compared with the control at PN 7 (Fig. 1G. Male: p<0.05) and PN 14 (Fig. 1J. Male: p<0.05), while the level of total caspase-3 was decreased at PN 7 (Fig. 1F. Male: p<0.05) and PN 14 (Fig. 1I. Male: p<0.05). Moreover, marked differences among the four groups of female offspring were not noted (Fig. 1F, Female; Fig. 1G, Female; Fig. 1I, Female; Fig. 1J, Female). These findings, therefore, suggested that maternal DEHP exposure induced CGC apoptosis in male rat offspring only.

Effects of maternal DEHP exposure on the PI3K/AKT signaling pathway

The PI3K/AKT/Bcl-2/Bax signaling pathway plays an important role in maintaining cell survival and function to regulate physiological processes such as cell apoptosis, division and differentiation [52,53]. In this investigation, for male pups, it was found that the expression of p-PI3K (Fig. 2B, Male: p<0.05; Fig. 3B, Male: p<0.05), p-AKT (Fig. 2D, Male: p<0.05; Fig. 3D, Male: p<0.05) and Bcl-2 (Fig. 2F, Male: p<0.05; Fig. 3F, Male: p<0.05) was significantly decreased in 300 and 750 mg/kg/d exposure groups at PN 7 and PN 14 in comparison with the control, and the protein expression of Bax from 300 and 750 mg/kg/d exposure groups was elevated (Fig. 2G, Male: p<0.05; Fig. 3G, Male: p<0.05). In addition, for female pups, no evident differences were found in the expression of p-PI3K (Fig. 2B, Female; Fig. 3B, Female), p-AKT (Fig. 2D, Female; Fig. 3D, Female), Bcl-2 (Fig. 2F, Female; Fig. 3F Female) and Bax (Fig. 2G, Female; Fig. 3G Female) at PN 7 and PN 14. Our results indicated that DEHP exposure during pregnancy and latency inhibited the PI3K/AKT signaling pathway of male offspring.

Effects of MEHP on cell viability of primary cerebellar granule cell

Cultured CGCs were identified by β-III tubulin, an appropriate marker for CGCs, which is located in the cytoplasm and axons [54]. CGCs are stained with red fluorescence in the cytoplasm and axons. Their purity was calculated by the ratio of the number of CGCs to the total number of cells. Three batches of cells and five fields per batch were selected to obtain this average. We found that the purity of primary cultured CGCs was about 95% and cells were used in subsequent experiments. CGCs cells were treated with MEHP at the indicated concentrations for 12 h, 24 h and 48 h, and cell viability was measured by CCK-8 assay. As shown in Fig. 4B, cell viability decreased with an increase in MEHP dose and exposure time. The results showed that 25 µM MEHP did not noticeably affect the cell viability of CGCs after 12 and 24 h exposure, but decreased it after 48 h exposure. Moreover, exposure to 250 µM MEHP for 24 h led to an approximately 20% reduction in cell viability when compared to the control (Fig. 4B, p<0.05). The cell viability was reduced to 50% when CGCs were exposed to 1000 µM MEHP for 24 h. Based on these results, we selected 0, 25, 100 and 250 µM as MEHP exposure concentrations and 24 h as the exposure time for subsequent experiments to eliminate the interference of DEHP-induced cell death.

MEHP induced CGC apoptosis through inhibiting the PI3K/AKT signaling pathway in vitro

Primary CGCs were stained by TUNEL and cleaved caspase-3 to evaluate apoptosis induced by MEHP in vitro. The percentage of TUNEL positive cells gradually increased in CGCs as the MEHP exposure concentration increased (Fig. 5B, p<0.05). We also found that the percentage of cleaved caspase-3 positive cells significantly increased in MEHP treatment groups in comparison with the control (Fig. 5D, p<0.05). Furthermore, the protein expression of cleaved caspase-3 was also upregulated in the three MEHP exposure groups when compared with the control (Fig. 5G, p<0.05), while the level of total caspase-3 was downregulated (Fig. 5F, p<0.05).

The PI3K/AKT signaling pathway was also measured after cultured CGCs were exposed to MEHP. The results showed that p- PI3K (Fig. 6B, p<0.05), p-AKT (Fig. 6D, p<0.05) and Bcl-2 (Fig. 6F, p<0.05) protein expression in MEHP exposure groups was significantly decreased when compared with the control, while the protein level of Bax (Fig. 6G, p<0.05) increased as the MEHP exposure concentration became elevated. In addition, there was no marked difference in total PI3K and AKT protein levels of the four independent groups (Fig. 6C, 6E). These results indicate that MEHP promoted CGC apoptosis via the PI3K/AKT signaling pathway in vitro.

IGF1 protects CGCs from apoptosis induced by MEHP via the PI3K/AKT pathway, while LY294002 aggravated apoptosis

IGF1 is considered to be an activator of the PI3K/AKT signaling pathway [55]. To further observe apoptosis induced by DEHP when the PI3K/AKT signaling pathway was activated, CGCs were pretreated with IGF1 (30, 50 and 100 ng/ml) for 2 h, and then treated with 250 µM MEHP for 24 h. Compared with the control group, the protein expression of Bax (Fig. 7G, p<0.05) and cleaved caspase-3 (Fig. 7I, p<0.05) increased in the MEHP only treatment group when compared with the control, while the levels of p-PI3K (Fig. 7B, p<0.05), p-Akt (Fig. 7D, p<0.05), Bcl-2 (Fig. 7F, p<0.05) and total caspase 3 (Fig. 7H, p<0.05) proteins decreased. In addition, combined treatment with IGF1 led to the recovery of levels of p-PI3K, p-AKT and Bcl-2 proteins, but decreased the expression of cleaved caspase-3 and Bax when compared to MEHP only treatment. Moreover, there was no obvious difference in the expression of these proteins between the IGF1 alone treatment and the control.

Furthermore, a TUNEL assay was performed to evaluate apoptosis after IGF1 treatment. We found that the number of cells that were TUNEL positive was reduced upon pretreatment with 100 ng/ml IGF1 in comparison with the MEHP only treatment group, and there was no evident difference between the control and IGF1 only treatment groups (Fig. 8B, p<0.05). Therefore, IGF1 protects CGCs from apoptosis induced by MEHP via the PI3K/AKT pathway.

In addition, to confirm that IGF1 could rescue the inhibitory effect of DHEP on CGC cell death via partially affecting PI-3K/AKT pathway, the PI3K/AKT signaling pathway in four groups were measured, including the control group and the experiment groups with LY294002 (chemical inhibitor of PI-3K), MEHP, and LY294002 plus MEHP. We found that DEHP had a similar effect to that of LY294002 in that it inhibited the PI3K/AKT signaling pathway (Fig. 9B, p<0.05; Fig. 9C, p<0.05; Fig. 9E, p<0.05; Fig. 9F, p<0.05; Fig. 9G, p<0.05; Fig. 9H, p<0.05) and increased the TUNEL positive rate in CGCs (Fig. 10B, p<0.05). Moreover, the inhibition effect is more obvious when applying both MEHP and LY294002.

DISCUSSION

DEHP is one of the most widespread endocrine-disrupting chemicals in the environment [56,57]. DEHP and its primary metabolite, MEHP, have also been found in human tissues such as blood, urine, breast milk and amniotic fluid [58,59]. An increasing number of studies has shown that exposure to DEHP during pregnancy and lactation is associated with cerebellar-related neurobehavioral disorders [60,61,62,63]. However, the direct effects of DEHP on the cerebellum and any related mechanisms have not been well studied. Therefore, in this study, we established an animal model of DEHP exposure and cultured primary CGCs exposed to MEHP to observe the effects on apoptosis of CGCs and the underlying mechanisms involved.

Neuronal apoptosis and survival are closely controlled processes that regulate cell fate and homeostasis during central nervous system development [64]. In the process of apoptosis, the activation of the caspase family plays a key role. Of these, caspase-3 is in a pivotal position. Upon activation, caspase-3 is cleaved to producing an active subunit of cleaved caspase-3, which can further activate nucleic acid endonuclease, break down DNA fragments and eventually induce apoptosis [65]. In this study, it was found that TUNEL positive cells in the internal granular layer of 300 mg/kg/d and 750 mg/kg/d exposure groups were increased when compared with the control group in male offspring at PN 7 and PN 14. Moreover, cleaved caspase-3 is also elevated in comparison with the control, while total caspase-3 is decreased. These results demonstrated that maternal exposure to DEHP could induce CGC apoptosis in male offspring, and the increased cleaved caspase-3 induced by DEHP might attributed to the increased proteolysis of pro-caspase-3. Similarly, another environmental endocrine disruptor significantly increased apoptotic cells in the brain [66]. To further verify whether DEHP played a role in promoting apoptosis, we cultured primary CGCs and exposed them to MEHP. MEHP is the main metabolite of DEHP in vivo , and is considered to be the primary substance that plays a role in toxicity [67,68]. We found that the number of cells that were TUNEL positive as well as cleaved caspase-3 expression significantly increased with increasing MEHP concentration while the total caspase 3 level decreased. Previous studies have also shown that MEHP exposure induced caspase-3 dependent apoptosis in neuronal cells [69,70]. These results indicated that DEHP induced CGC apoptosis.

The PI3K/AKT signaling pathway plays a crucial role in neuronal cell survival [71,72,73]. Activation of PI3K can phosphorylate and activate AKT by binding to its PH region of it, causing the translocation of AKT to the inner surface of the cell membrane [74,75,76]. Phosphorylated AKT (p-AKT) can further activate downstream signals, such as Bcl-2 and Bax, which participate in growth, development, differentiation and cell survival [77]. Bcl-2 promotes cell survival by blocking cell apoptosis, while Bax, in contrast to Bcl-2, induces cell apoptosis [78,79]. In this investigation, we found that p-PI3K, p-AKT, Bcl-2 and total caspase-3 expression decreased in male offspring after maternal exposure to 300mg/kg/d and 750 mg/kg/d DEHP, while Bax and cleaved caspase 3 expression increased. These results indicated that PI3K/AKT may be involved in the CGC apoptosis induced by DEHP. Meanwhile, the PI3K/AKT signaling pathway was measured in primary CGCs after exposure to MEHP, showing that the signaling pathway was also inhibited. In line with these results, other studies have shown that the PI3K/AKT pathway plays an important role in inhibiting neuronal cell apoptosis and increasing cell survival [80,81,82].

Various neurotrophic factors inhibit apoptosis and play a protective role in neurodevelopment by activating the PI3K/AKT signaling pathway [83,84,85]. As a neurotrophic factor, IGF1 can regulate cell growth and differentiation, and protect neurons from death induced by many stimuli [86]. IGF1 can activate PI3K by binding to insulin-like growth factor receptor (IGF1R) on the cell membrane, which is capable of phosphorylating downstream AKT and then inducing cascade changes of downstream substrates [87,88,89]. IGF1 can prevent apoptosis via the PI3K/AKT signaling pathway [90,91]. In order to demonstrate whether apoptosis decreased when the PI3K/AKT signaling pathway is activated, exogenous IGF1 was added to CGCs in vitro and the apoptotic level and PI3K/AKT signaling pathway then measured. We found that IGF1 reduced apoptosis in CGCs caused by MEHP, as seen in the significantly decreased number of TUNEL positive cell and reduced cleaved caspase 3 protein expression. Furthermore, the protective effect of IGF1 on CGCs was by activating the PI3K/AKT signaling pathway. Meanwhile, LY294002 aggravated apoptosis via inhibiting the signaling pathway. Taken together, these results indicated that the activation of the PI3K/AKT signaling pathway may partially rescue increased apoptosis in CGCs exposed to MEHP.

Our results showed an interesting phenomenon in that male offspring seemed to be more susceptible to DEHP exposure than female offspring. We speculated that the vulnerability of male rats to DEHP exposure may involve decreased estrogen levels through the suppression of aromatase activity in the male brain according to previous reports [92,93]. Our previous work also demonstrated that aromatase expression and the estrogen level in the 300 and 750 mg/kg/d DEHP exposure groups significantly decreased when compared to the controls for male offspring, but did not have an evident effect on females [94]. Aromatase activity is the key enzyme in the transformation of peripheral circulating androgens to estrogens, which is the primary source of this hormone in the male brain [95], and estrogen plays an important role in CGC development [96]. Therefore, it has been speculated that DEHP affects cerebellar development by interfering with the synthesis of estrogen, making male cubs more susceptible to DEHP. Similarly, epidemiological studies have found that some neurological damage is more pronounced in men [97,98,99].

In summary, DEHP and its metabolite MEHP induced apoptosis of CGCs. The apoptosis induced by DEHP was associated with the inhibition of the PI3K/AKT signaling pathway. Furthermore, IGF1 may partially protect CGCs from apoptosis and LY294002 can aggravate it (Fig. 11). These findings indicate that DEHP exposure induced apoptosis in CGCs via the PI3K/AKT signaling pathway. Understanding the pathological effect of DEHP exposure may bring in treatments for DEHP overexposure. Also, a line on future research directions would be useful.

Figures

Fig. 1. Effect of maternal DEHP exposure on cerebellar granule cell apoptosis in pups. Representative photomicrographs show fluorescence staining of terminal deoxynucleotidyl transferase-mediated dUTP nick-and labeling (TUNEL)-positive cells in the internal granular layer of cerebellum in the four groups (0, 30, 300 and 750 mg/kg/d). (A) Postnatal (PN) day 7 for males and females, (B) PN 14 for males and females. Corresponding bar graph shows the TUNEL-positive cell count in the four groups.at PN 7 (C) and PN 14 (D). Scale bar=25 µm. The scale bar is the same for all images in the figure. Western blots bands represent the expression of cleaved caspase-3 and caspase 3 for male and female offspring at PN 7 (E) and PN 14 (H). Semi-quantitative measurements of cleaved caspase-3 and total caspase 3 for male and female offspring at PN 7 (F) (G) and PN 14 (I) (J). With each time point, *p<0.05 vs control, #p<0.05 vs 30 mg/kg/d contamination group (n=6).
Fig. 2. Effect of maternal DEHP exposure on PI3K/AKT signaling pathway of pups at PN 7. (A) Western blot bands represent the expression level of proteins in the PI3K/AKT/Bcl-2/Bax pathway at PN 7 for males and females. The bar graphs show the results of the semi-quantitative measurement of p-PI3K (B), PI3K (C), p-AKT (D), AKT (E), Bcl-2 (F) and Bax (G). Each bar represents mean ± standard deviation (SD). The mean expression in offspring from 0, 30, 300, and 750 mg/kg/d exposure groups is shown as a fold-change compared to the mean expression in the 0 mg/kg/d group which was ascribed an arbitrary value of 1. With each time point, *p<0.05 vs control, #p<0.05 vs 30 mg/kg/d contamination group (n=6).
Fig. 3. Effect of maternal DEHP exposure on PI3K/AKT signaling pathway of pups at PN 14. (A) Western blot bands represent the expression level of proteins in PI3K/AKT/Bcl-2/Bax pathway at PN 14 for males and females. The bar graphs show the results of the semi-quantitative measurement of p-PI3K (B), PI3K (C), p-AKT (D), AKT (E), Bcl-2 (F) and Bax (G). Each bar represents mean±SD. The mean expression in offspring from the 0, 30, 300, and 750 mg/kg/d exposure groups is shown as a fold-change compared to the mean expression in the 0 mg/kg/d group which was ascribed an arbitrary value of 1. With each time point, *p<0.05 vs control, #p<0.05 vs 30 mg/kg/d contamination group (n=6).
Fig. 4. Effects of MEHP on cell viability of primary CGCs. (A) Representative photomicrographs show the intact morphological structure of primary cerebellar granule cell neurons. Positive staining cells (yellow arrow) are CGCs and negative staining cells (white arrow) indicate non-CGCs, Scale bar=100 µm. (B) CGCs were exposed to various concentrations of mono-(2-ethylhexyl) phthalate (MEHP; 0~1000 µM) for 12 h, 24 h and 48 h, and cell viability was measured by CCK-8 kit. Data are expressed as the mean±SD for three independent experiments. Each assay was performed in triplicate *p<0.05 vs control.
Fig. 5. MEHP induces CGC apoptosis in vitro. Cultured cerebellar granule cells (CGCs) were treated with 25, 100 and 250 µM MEHP for 24 h. (A) Representative photomicrographs show the percentage of TUNEL positive CGCs in the four different exposure groups. (B) Corresponding bar graph shows TUNEL positive rate of CGCs in the four groups. (C) Representative photomicrographs show the percentage of CGCs with cleaved caspase-3 positive cells in the four groups. (D) The bar graph shows the percentage of CGCs with cleaved caspase-3 in the four exposure groups. (E) Western blot showing the expression of cleaved caspase-3 after MEHP exposure in vitro (F) Semi-quantitative measurements of cleaved caspase-3 for the four groups. (G) Semi-quantitative measurements of caspase-3 for the four groups. *p<0.05 vs control, #p<0.05 vs 25 µM MEHP exposure group, & p<0.05 vs 100 µM MEHP exposure group. Scale bar=25 µM. The scale bar is the same for all images in the figure.
Fig. 6. MEHP disturbed the PI3K/AKT signaling pathway of CGCs in vitro. (A) Western blot bands represent the expression level of proteins in the PI3K/AKT/Bcl2/Bax pathway in the four MEHP exposure (0, 25, 100 and 250 µM) groups of primary CGCs. The corresponding bar graphs show the results of the semi-quantitative measurement of p-PI3K (B), PI3K (C), p-AKT (D), AKT (E), Bcl-2 (F) and Bax (G). Each bar represents the mean±SD. Mean expression in CGCs from each MEHP exposure group is shown as a fold-change compared to the mean expression in the control group that has been ascribed an arbitrary value of 1. With each time point, *p<0.05 vs control, #p<0.05 vs 250 µM MEHP exposure group, & p<0.05 vs 100 µM MEHP exposure group (n=4).
Fig. 7. IGF1 protects CGCs from apoptosis induced by MEHP by activating the PI3K/AKT pathway. CGCs were pre-treated with 30, 50 and 100 ng/mL of insulin-like growth factor (IGF) 1, an activator of the PI3K/AKT, signaling pathway, for 2 h followed by treatment with 250 MEHP for 24 h. (A) Western blot bands represent the expression of proteins in the PI3K/AKT/Bcl-2/Bax pathway. (B~I) Each column represents the mean±SD. The mean expression in CGCs from each group is shown as a fold-change compared to the mean expression in the control group which was ascribed an arbitrary value of 1. With each time point, *p<0.05 vs control, #p<0.05 vs MEHP only treatment group (n=4).
Fig. 8. IGF1 reduced apoptosis caused by MEHP exposure in vitro. CGCs were pre-treated with 100 ng/mL IGF1 for 2 h, and then treated with 250 µM MEHP for 24h. (A) Representative photomicrographs show TUNEL positive cells in the four indicated exposure groups. (B) The corresponding graph shows percentage of TUNEL positive cells in the four groups. Scale bar=25 µm, *p<0.05 vs control, #p<0.05 vs MEHP only treatment (n=4).
Fig. 9. LY294002 aggravated the suppression of PI3K/AKT signaling pathway induced by MEHP. CGCs were pre-treated with 5 µM of LY294002, an inhibitor of PI-3K/AKT pathway, for 2 h followed by treatment with 250 MEHP for 24 h. The corresponding graphs the semi-quantitative measurement of PI3K (B), p-AKT (C), AKT (D), Bcl-2 (E), Bax (F), total caspase-3 (G) and cleaved caspase-3 (H). Each column represents the mean±SD. Mean expression in CGCs from each MEHP exposure group is shown as a fold-change compared to the mean expression in the control group, which was ascribed an arbitrary value of 1. With each time point, *p<0.05 vs control, #p<0.05 vs 250 µM MEHP exposure group (n=4).
Fig. 10. LY294002 exacerbated apoptosis caused by MEHP exposure in vitro. (A) Representative photomicrographs show TUNEL positive cells in the four indicated exposure groups. (B) The corresponding graph shows percentage of TUNEL positive cells in the four groups. Scale bar=25 µm *p<0.05 vs control, #p<0.05 vs MEHP only treatment (n=4).
Fig. 11. Di-(2-ethylhexyl) phthalate (DEHP) induce apoptosis of cerebellar granule cells (CGCs). The apoptosis induced by DEHP is associated with inhibition of the PI3K/AKT signaling pathway. Insulin-like growth factor (IGF) 1 may partially protect CGCs from apoptosis and LY294002 aggravated the apoptosis induced by DEHP.

References

  1. Zhang T, Shen W, De Felici M, Zhang XF. Di(2-ethylhexyl) phthalate: adverse effects on folliculogenesis that cannot be neglected. Environ Mol Mutagen 2016;57:579-588.
    Pubmed
  2. García Ibarra V, Rodríguez Bernaldo de Quirós A, Paseiro Losada P, Sendón R. Identification of intentionally and non-intentionally added substances in plastic packaging materials and their migration into food products. Anal Bioanal Chem 2018;410:3789-3803.
  3. Bernard L, Décaudin B, Lecoeur M, Richard D, Bourdeaux D, Cueff R, Sautou V, Armed Study Group. Analytical methods for the determination of DEHP plasticizer alternatives present in medical devices: a review. Talanta 2014;129:39-54.
    Pubmed
  4. Braun JM, Sathyanarayana S, Hauser R. Phthalate exposure and children's health. Curr Opin Pediatr 2013;25:247-254.
    Pubmed
  5. Erythropel HC, Maric M, Nicell JA, Leask RL, Yargeau V. Leaching of the plasticizer di(2-ethylhexyl)phthalate (DEHP) from plastic containers and the question of human exposure. Appl Microbiol Biotechnol 2014;98:9967-9981.
    Pubmed
  6. Junaid M, Jia PP, Tang YM, Xiong WX, Huang HY, Strauss PR, Li WG, Pei DS. Mechanistic toxicity of DEHP at environmentally relevant concentrations (ERCs) and ecological risk assessment in the Three Gorges Reservoir Area, China. Environ Pollut 2018;242:1939-1949.
    Pubmed
  7. Mankidy R, Wiseman S, Ma H, Giesy JP. Biological impact of phthalates. Toxicol Lett 2013;217:50-58.
    Pubmed
  8. Bakir A, O'Connor IA, Rowland SJ, Hendriks AJ, Thompson RC. Relative importance of microplastics as a pathway for the transfer of hydrophobic organic chemicals to marine life. Environ Pollut 2016;219:56-65.
    Pubmed
  9. Lee KI, Chiang CW, Lin HC, Zhao JF, Li CT, Shyue SK, Lee TS. Maternal exposure to di-(2-ethylhexyl) phthalate exposure deregulates blood pressure, adiposity, cholesterol metabolism and social interaction in mouse offspring. Arch Toxicol 2016;90:1211-1224.
    Pubmed
  10. Wittassek M, Angerer J. Phthalates: metabolism and exposure. Int J Androl 2008;31:131-138.
    Pubmed
  11. Shea KM, American Academy of Pediatrics Committee on Environmental Health. Pediatric exposure and potential toxicity of phthalate plasticizers. Pediatrics 2003;111:1467-1474.
    Pubmed
  12. Buckley JP, Palmieri RT, Matuszewski JM, Herring AH, Baird DD, Hartmann KE, Hoppin JA. Consumer product exposures associated with urinary phthalate levels in pregnant women. J Expo Sci Environ Epidemiol 2012;22:468-475.
    Pubmed
  13. Wang B, Liu F, Dong J, You M, Fu Y, Li C, Lu Y, Chen J. Maternal exposure to environmental DEHP exacerbated OVA-induced asthmatic responses in rat offspring. Sci Total Environ 2018;615:253-261.
    Pubmed
  14. Fromme H, Gruber L, Seckin E, Raab U, Zimmermann S, Kiranoglu M, Schlummer M, Schwegler U, Smolic S, Völkel W, HBMnet. Phthalates and their metabolites in breast milk--results from the Bavarian Monitoring of Breast Milk (BAMBI). Environ Int 2011;37:715-722.
    Pubmed
  15. You M, Dong J, Fu Y, Cong Z, Fu H, Wei L, Wang Y, Wang Y, Chen J. Exposure to Di-(2-ethylhexyl) phthalate during perinatal period gender-specifically impairs the dendritic growth of pyramidal neurons in rat offspring. Front Neurosci 2018;12:444.
    Pubmed
  16. Sathyanarayana S, Grady R, Barrett ES, Redmon B, Nguyen RH, Barthold JS, Bush NR, Swan SH. First trimester phthalate exposure and male newborn genital anomalies. Environ Res 2016;151:777-782.
    Pubmed
  17. Wang Y, Yang Q, Liu W, Yu M, Zhang Z, Cui X. DEHP exposure in utero disturbs sex determination and is potentially linked with precocious puberty in female mice. Toxicol Appl Pharmacol 2016;307:123-129.
    Pubmed
  18. de Cock M, de Boer MR, Lamoree M, Legler J, van de Bor M. Prenatal exposure to endocrine disrupting chemicals in relation to thyroid hormone levels in infants - a Dutch prospective cohort study. Environ Health 2014;13:106.
    Pubmed
  19. Tang C, Deng Y, Duan H, Yi Z, Li Y, Qiu D, Zhou K, Hua Y, Wang C. The effect of maternal exposure to di-(2-ethylhexyl)-phthalate on fetal cardiac development in mice. J Appl Toxicol 2018;38:834-842.
    Pubmed
  20. Hatten ME, Heintz N. Mechanisms of neural patterning and specification in the developing cerebellum. Annu Rev Neurosci 1995;18:385-408.
    Pubmed
  21. Hatten ME, Roussel MF. Development and cancer of the cerebellum. Trends Neurosci 2011;34:134-142.
    Pubmed
  22. Wang SS, Kloth AD, Badura A. The cerebellum, sensitive periods, and autism. Neuron 2014;83:518-532.
    Pubmed
  23. Wagner MJ, Kim TH, Savall J, Schnitzer MJ, Luo L. Cerebellar granule cells encode the expectation of reward. Nature 2017;544:96-100.
    Pubmed
  24. Brun SN, Markant SL, Esparza LA, Garcia G, Terry D, Huang JM, Pavlyukov MS, Li XN, Grant GA, Crawford JR, Levy ML, Conway EM, Smith LH, Nakano I, Berezov A, Greene MI, Wang Q, Wechsler-Reya RJ. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma. Oncogene 2015;34:3770-3779.
    Pubmed
  25. Scheuer T, Sharkovska Y, Tarabykin V, Marggraf K, Brockmöller V, Bührer C, Endesfelder S, Schmitz T. Neonatal hyperoxia perturbs neuronal development in the cerebellum. Mol Neurobiol 2018;55:3901-3915.
    Pubmed
  26. Wang Y, Hersheson J, Lopez D, Hammer M, Liu Y, Lee KH, Pinto V, Seinfeld J, Wiethoff S, Sun J, Amouri R, Hentati F, Baudry N, Tran J, Singleton AB, Coutelier M, Brice A, Stevanin G, Durr A, Bi X, Houlden H, Baudry M. Defects in the CAPN1 gene result in alterations in cerebellar development and cerebellar ataxia in mice and humans. Cell Reports 2016;16:79-91.
    Pubmed
  27. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007;35:495-516.
    Pubmed
  28. Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W, Moghadam AR, Kashani HH, Hashemi M, Owji AA, Łos MJ. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol 2014;112:24-49.
    Pubmed
  29. Zhang L, Fang Y, Cheng X, Lian YJ, Xu HL. Silencing of long noncoding RNA SOX21-AS1 relieves neuronal oxidative stress injury in mice with Alzheimer's disease by upregulating FZD3/5 via the Wnt signaling pathway. Mol Neurobiol (in press) 2018.
  30. Vila M, Przedborski S. Targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci 2003;4:365-375.
    Pubmed
  31. Charriaut-Marlangue C, Remolleau S, Aggoun-Zouaoui D, Ben-Ari Y. Apoptosis and programmed cell death: a role in cerebral ischemia. Biomed Pharmacother 1998;52:264-269.
    Pubmed
  32. Fu Z, Yang J, Wei Y, Li J. Effects of piceatannol and pterostilbene against β-amyloid-induced apoptosis on the PI3K/AKT/Bad signaling pathway in PC12 cells. Food Funct 2016;7:1014-1023.
    Pubmed
  33. Qi D, Ouyang C, Wang Y, Zhang S, Ma X, Song Y, Yu H, Tang J, Fu W, Sheng L, Yang L, Wang M, Zhang W, Miao L, Li T, Huang X, Dong H. HO-1 attenuates hippocampal neurons injury via the activation of BDNF-TrkB-PI3K/AKT signaling pathway in stroke. Brain Res 2014;1577:69-76.
    Pubmed
  34. Kim EH, Suresh M. Role of PI3K/AKT signaling in memory CD8 T cell differentiation. Front Immunol 2013;4:20.
    Pubmed
  35. Martini M, De Santis MC, Braccini L, Gulluni F, Hirsch E. PI3K/AKT signaling pathway and cancer: an updated review. Ann Med 2014;46:372-383.
    Pubmed
  36. Yang H, Lee MH, Park I, Jeon H, Choi J, Seo S, Kim SW, Koh GY, Park KS, Lee DH. HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2. Cancer Lett 2017;411:19-26.
    Pubmed
  37. Hers I, Vincent EE, Tavaré JM. AKT signalling in health and disease. Cell Signal 2011;23:1515-1527.
    Pubmed
  38. Russo A, Cardile V, Graziano A, Avola R, Bruno M, Rigano D. Involvement of Bax and Bcl-2 in induction of apoptosis by essential oils of three Lebanese Salvia species in human prostate cancer cells. Int J Mol Sci 2018;19:292.
  39. Law NC, White MF, Hunzicker-Dunn ME. G protein-coupled receptors (GPCRs) that signal via protein kinase A (PKA) cross-talk at insulin receptor substrate 1 (IRS1) to activate the phosphatidylinositol 3-kinase (PI3K)/AKT pathway. J Biol Chem 2016;291:27160-27169.
    Pubmed
  40. Barakat R, Lin PC, Park CJ, Best-Popescu C, Bakry HH, Abosalem ME, Abdelaleem NM, Flaws JA, Ko C. Prenatal exposure to DEHP induces neuronal degeneration and neurobehavioral abnormalities in adult male mice. Toxicol Sci 2018;164:439-452.
    Pubmed
  41. Smith CA, Macdonald A, Holahan MR. Acute postnatal exposure to di(2-ethylhexyl) phthalate adversely impacts hippocampal development in the male rat. Neuroscience 2011;193:100-108.
    Pubmed
  42. Park S, Lee JM, Kim JW, Cheong JH, Yun HJ, Hong YC, Kim Y, Han DH, Yoo HJ, Shin MS, Cho SC, Kim BN. Association between phthalates and externalizing behaviors and cortical thickness in children with attention deficit hyperactivity disorder. Psychol Med 2015;45:1601-1612.
    Pubmed
  43. Komada M, Gendai Y, Kagawa N, Nagao T. Prenatal exposure to di(2-ethylhexyl) phthalate impairs development of the mouse neocortex. Toxicol Lett 2016;259:69-79.
    Pubmed
  44. Win-Shwe TT, Yanagisawa R, Koike E, Nitta H, Takano H. Expression levels of neuroimmune biomarkers in hypothalamus of allergic mice after phthalate exposure. J Appl Toxicol 2013;33:1070-1078.
    Pubmed
  45. Carbone S, Szwarcfarb B, Ponzo O, Reynoso R, Cardoso N, Deguiz L, Moguilevsky JA, Scacchi P. Impact of gestational and lactational phthalate exposure on hypothalamic content of amino acid neurotransmitters and FSH secretion in peripubertal male rats. Neurotoxicology 2010;31:747-751.
    Pubmed
  46. Hirosawa N, Yano K, Suzuki Y, Sakamoto Y. Endocrine disrupting effect of di-(2-ethylhexyl)phthalate on female rats and proteome analyses of their pituitaries. Proteomics 2006;6:958-971.
    Pubmed
  47. Moore RW, Rudy TA, Lin TM, Ko K, Peterson RE. Abnormalities of sexual development in male rats with in utero and lactational exposure to the antiandrogenic plasticizer di(2-ethylhexyl) phthalate. Environ Health Perspect 2001;109:229-237.
    Pubmed
  48. Sato M, Suzuki K, Nakanishi S. NMDA receptor stimulation and brain-derived neurotrophic factor upregulate homer 1a mRNA via the mitogen-activated protein kinase cascade in cultured cerebellar granule cells. J Neurosci 2001;21:3797-3805.
    Pubmed
  49. Krämer D, Minichiello L. Cell culture of primary cerebellar granule cells. Methods Mol Biol 2010;633:233-239.
    Pubmed
  50. Qiu W, Carson-Walter EB, Liu H, Epperly M, Greenberger JS, Zambetti GP, Zhang L, Yu J. PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell 2008;2:576-583.
    Pubmed
  51. Parrish AB, Freel CD, Kornbluth S. Cellular mechanisms controlling caspase activation and function. Cold Spring Harb Perspect Biol 2013;5:a008672.
    Pubmed
  52. Wolin EM. PI3K/AKT/mTOR pathway inhibitors in the therapy of pancreatic neuroendocrine tumors. Cancer Lett 2013;335:1-8.
    Pubmed
  53. Mayer IA, Arteaga CL. The PI3K/AKT pathway as a target for cancer treatment. Annu Rev Med 2016;67:11-28.
    Pubmed
  54. Collins LL, Williamson MA, Thompson BD, Dever DP, Gasiewicz TA, Opanashuk LA. 2,3,7,8-Tetracholorodibenzo-p-dioxin exposure disrupts granule neuron precursormaturation in the developing mouse cerebellum. Toxicol Sci 2008;103:125-136.
    Pubmed
  55. Suman S, Kallakury BV, Fornace AJ, Datta K. Protracted upregulation of leptin and IGF1 is associated with activation of PI3K/AKT and JAK2 pathway in mouse intestine after ionizing radiation exposure. Int J Biol Sci 2015;11:274-283.
    Pubmed
  56. Zhang C, Xie M, Chen J, Zhang Y, Wei S, Ma X, Xiao L, Chen L. UV-B radiation induces DEHP degradation and their combined toxicological effects on Scenedesmus acuminatus. Aquat Toxicol 2018;203:172-178.
    Pubmed
  57. Qin X, Ma Q, Yuan J, Hu X, Tan Q, Zhang Z, Wang L, Xu X. The effects of di-2-ethylhexyl phthalate on testicular ultrastructure and hormone-regulated gene expression in male rats. Toxicol Res (Camb) 2018;7:408-414.
    Pubmed
  58. Quinnies KM, Doyle TJ, Kim KH, Rissman EF. Transgenerational effects of di-(2-ethylhexyl) phthalate (DEHP) on stress hormones and behavior. Endocrinology 2015;156:3077-3083.
    Pubmed
  59. Wojtowicz AK, Sitarz-Glownia AM, Szczesna M, Szychowski KA. The action of di-(2-ethylhexyl) phthalate (DEHP) in mouse cerebral cells involves an impairment in aryl hydrocarbon receptor (AhR) signaling. Neurotox Res (in press) 2018.
  60. Engel SM, Villanger GD, Nethery RC, Thomsen C, Sakhi AK, Drover SS, Hoppin JA, Zeiner P, Knudsen GP, Reichborn-Kjennerud T, Herring AH, Aase H. Prenatal phthalates, maternal thyroid function, and risk of attention-deficit hyperactivity disorder in the norwegian mother and child cohort. Environ Health Perspect 2018;126:057004.
    Pubmed
  61. Verstraete S, Vanhorebeek I, Covaci A, Güiza F, Malarvannan G, Jorens PG, Van den Berghe G. Circulating phthalates during critical illness in children are associated with long-term attention deficit: a study of a development and a validation cohort. Intensive Care Med 2016;42:379-392.
    Pubmed
  62. Gascon M, Valvi D, Forns J, Casas M, Martínez D, Júlvez J, Monfort N, Ventura R, Sunyer J, Vrijheid M. Prenatal exposure to phthalates and neuropsychological development during childhood. Int J Hyg Environ Health 2015;218:550-558.
    Pubmed
  63. Du ZH, Xia J, Sun XC, Li XN, Zhang C, Zhao HS, Zhu SY, Li JL. A novel nuclear xenobiotic receptors (AhR/PXR/CAR)-mediated mechanism of DEHP-induced cerebellar toxicity in quails (Coturnix japonica) via disrupting CYP enzyme system homeostasis. Environ Pollut 2017;226:435-443.
    Pubmed
  64. Cavallaro S. Cracking the code of neuronal apoptosis and survival. Cell Death Dis 2015;6:e1963.
    Pubmed
  65. Choi BH, Kim W, Wang QC, Kim DC, Tan SN, Yong JW, Kim KT, Yoon HS. Kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells. Cancer Lett 2008;261:37-45.
    Pubmed
  66. Wang F, Fang M, Hinton DE, Chernick M, Jia S, Zhang Y, Xie L, Dong W, Dong W. Increased coiling frequency linked to apoptosis in the brain and altered thyroid signaling in zebrafish embryos (Danio rerio) exposed to the PBDE metabolite 6-OH-BDE-47. Chemosphere 2018;198:342-350.
    Pubmed
  67. Mittermeier A, Völkel W, Fromme H. Kinetics of the phthalate metabolites mono-2-ethylhexyl phthalate (MEHP) and mono-n-butyl phthalate (MnBP) in male subjects after a single oral dose. Toxicol Lett 2016;252:22-28.
    Pubmed
  68. Erkekoğlu P, Rachidi W, De Rosa V, Giray B, Favier A, Hincal F. Protective effect of selenium supplementation on the genotoxicity of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate treatment in LNCaP cells. Free Radic Biol Med 2010;49:559-566.
    Pubmed
  69. Aung KH, Win-Shwe TT, Kanaya M, Takano H, Tsukahara S. Involvement of hemeoxygenase-1 in di(2-ethylhexyl) phthalate (DEHP)-induced apoptosis of Neuro-2a cells. J Toxicol Sci 2014;39:217-229.
    Pubmed
  70. Lim CK, Kim SK, Ko DS, Cho JW, Jun JH, An SY, Han JH, Kim JH, Yoon YD. Differential cytotoxic effects of mono-(2-ethylhexyl) phthalate on blastomere-derived embryonic stem cells and differentiating neurons. Toxicology 2009;264:145-154.
    Pubmed
  71. Tu L, Wang Y, Chen D, Xiang P, Shen J, Li Y, Wang S. Protective Effects of notoginsenoside R1 via regulation of the PI3K-AKT-mTOR/JNK pathway in neonatal cerebral hypoxic-ischemic brain injury. Neurochem Res 2018;43:1210-1226.
    Pubmed
  72. Srivastava P, Dhuriya YK, Kumar V, Srivastava A, Gupta R, Shukla RK, Yadav RS, Dwivedi HN, Pant AB, Khanna VK. PI3K/AKT/GSK3β induced CREB activation ameliorates arsenic mediated alterations in NMDA receptors and associated signaling in rat hippocampus: neuroprotective role of curcumin. Neurotoxicology 2018;67:190-205.
    Pubmed
  73. Chen J, Alberts I, Li X. Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders. Int J Dev Neurosci 2014;35:35-41.
    Pubmed
  74. Zhang L, Zhou F, ten Dijke P. Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer. Trends Biochem Sci 2013;38:612-620.
    Pubmed
  75. Narla G, Sangodkar J, Ryder CB. The impact of phosphatases on proliferative and survival signaling in cancer. Cell Mol Life Sci 2018;75:2695-2718.
    Pubmed
  76. Chalhoub N, Zhu G, Zhu X, Baker SJ. Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains. Genes Dev 2009;23:1619-1624.
    Pubmed
  77. Feng M, Li J, Wang J, Ma C, Jiao Y, Wang Y, Zhang J, Sun Q, Ju Y, Gao L, Zhao Y. High glucose increases LPS-induced DC apoptosis through modulation of ERK1/2, AKT and Bax/Bcl-2. BMC Gastroenterol 2014;14:98.
    Pubmed
  78. Mei JM, Niu CS. Effects of CDNF on 6-OHDA-induced apoptosis in PC12 cells via modulation of Bcl-2/Bax and caspase-3 activation. Neurol Sci 2014;35:1275-1280.
    Pubmed
  79. Maes ME, Schlamp CL, Nickells RW. BAX to basics: how the BCL2 gene family controls the death of retinal ganglion cells. Prog Retin Eye Res 2017;57:1-25.
    Pubmed
  80. Nakanishi A, Wada Y, Kitagishi Y, Matsuda S. Link between PI3K/AKT/PTEN pathway and NOX proteinin diseases. Aging Dis 2014;5:203-211.
    Pubmed
  81. Kitagishi Y, Matsuda S. Diets involved in PPAR and PI3K/AKT/PTEN pathway may contribute to neuroprotection in a traumatic brain injury. Alzheimers Res Ther 2013;5:42.
    Pubmed
  82. Vázquez de la Torre A, Junyent F, Folch J, Pelegrí C, Vilaplana J, Auladell C, Beas-Zarate C, Pallàs M, Verdaguer E, Camins A. PI3 K/AKT inhibition induces apoptosis through p38 activation in neurons. Pharmacol Res 2013;70:116-125.
    Pubmed
  83. Ding ML, Ma H, Man YG, Lv HY. Protective effects of a green tea polyphenol, epigallocatechin-3-gallate, against sevoflurane-induced neuronal apoptosis involve regulation of CREB/BDNF/TrkB and PI3K/AKT/mTOR signalling pathways in neonatal mice. Can J Physiol Pharmacol 2017;95:1396-1405.
    Pubmed
  84. Mnich K, Carleton LA, Kavanagh ET, Doyle KM, Samali A, Gorman AM. Nerve growth factor-mediated inhibition of apoptosis post-caspase activation is due to removal of active caspase-3 in a lysosome-dependent manner. Cell Death Dis 2014;5:e1202.
    Pubmed
  85. Jie B, Zhang X, Wu X, Xin Y, Liu Y, Guo Y. Neuregulin-1 suppresses cardiomyocyte apoptosis by activating PI3K/AKT and inhibiting mitochondrial permeability transition pore. Mol Cell Biochem 2012;370:35-43.
    Pubmed
  86. Haramoto Y, Takahashi S, Oshima T, Onuma Y, Ito Y, Asashima M. Insulin-like factor regulates neural induction through an IGF1 receptor-independent mechanism. Sci Rep 2015;5:11603.
    Pubmed
  87. Pang Y, Zheng B, Fan LW, Rhodes PG, Cai Z. IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/AKT and interruption of the mitochondrial apoptotic pathway. Glia 2007;55:1099-1107.
    Pubmed
  88. Mani AM, Fenwick MA, Cheng Z, Sharma MK, Singh D, Wathes DC. IGF1 induces up-regulation of steroidogenic and apoptotic regulatory genes via activation of phosphatidylinositol-dependent kinase/AKT in bovine granulosa cells. Reproduction 2010;139:139-151.
    Pubmed
  89. Ikink GJ, Boer M, Bakker ER, Hilkens J. IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K/AKT-pathway hyperactivation. Nat Commun 2016;7:13567.
    Pubmed
  90. Liao R, Yan F, Zeng Z, Wang H, Qiu K, Xu J, Zheng W. Insulin-like growth factor-1 activates PI3K/AKT signalling to protect human retinal pigment epithelial cells from amiodarone-induced oxidative injury. Br J Pharmacol 2018;175:125-139.
    Pubmed
  91. Zhang M, Liu J, Li M, Zhang S, Lu Y, Liang Y, Zhao K, Li Y. Insulin-like growth factor 1/insulin-like growth factor 1 receptor signaling protects against cell apoptosis through the PI3K/AKT pathway in glioblastoma cells. Exp Ther Med 2018;16:1477-1482.
    Pubmed
  92. Andrade AJ, Grande SW, Talsness CE, Grote K, Chahoud I. A dose-response study following in utero and lactational exposure to di-(2-ethylhexyl)-phthalate (DEHP): nonmonotonic dose-response and low dose effects on rat brain aromatase activity. Toxicology 2006;227:185-192.
    Pubmed
  93. Borch J, Metzdorff SB, Vinggaard AM, Brokken L, Dalgaard M. Mechanisms underlying the anti-androgenic effects of diethylhexyl phthalate in fetal rat testis. Toxicology 2006;223:144-155.
    Pubmed
  94. Fu Y, Dong J, You M, Cong Z, Wei L, Fu H, Wang Y, Wang Y, Chen J. Maternal di-(2-ethylhexyl) phthalate exposure inhibits cerebellar granule precursor cell proliferation via down-regulating the Shh signaling pathway in male offspring. Chemosphere 2019;215:313-322.
    Pubmed
  95. Wu MV, Manoli DS, Fraser EJ, Coats JK, Tollkuhn J, Honda S, Harada N, Shah NM. Estrogen masculinizes neural pathways and sex-specific behaviors. Cell 2009;139:61-72.
    Pubmed
  96. Cookman CJ, Belcher SM. Estrogen receptor-β up-regulates IGF1R expression and activity to inhibit apoptosis and increase growth of medulloblastoma. Endocrinology 2015;156:2395-2408.
    Pubmed
  97. Yolton K, Xu Y, Strauss D, Altaye M, Calafat AM, Khoury J. Prenatal exposure to bisphenol A and phthalates and infant neurobehavior. Neurotoxicol Teratol 2011;33:558-566.
    Pubmed
  98. Kim Y, Ha EH, Kim EJ, Park H, Ha M, Kim JH, Hong YC, Chang N, Kim BN. Prenatal exposure to phthalates and infant development at 6 months: prospective Mothers and Children's Environmental Health (MOCEH) study. Environ Health Perspect 2011;119:1495-1500.
    Pubmed
  99. Cho SC, Bhang SY, Hong YC, Shin MS, Kim BN, Kim JW, Yoo HJ, Cho IH, Kim HW. Relationship between environmental phthalate exposure and the intelligence of school-age children. Environ Health Perspect 2010;118:1027-1032.
    Pubmed

Print ISSN : 1226-2560

Online ISSN : 2093-8144

© 2019. Experimental Neurobiology: the official journal of the Korean Society for Brain and Neural Sciences & the Korean Society for Neurodegenerative Disease.